Activation of endothelial TrkB receptors induces relaxation of resistance arteries

Vascul Pharmacol. 2018 Jul:106:46-53. doi: 10.1016/j.vph.2018.02.005. Epub 2018 Feb 20.

Abstract

While brain-derived neurotrophic factor (BDNF) was previously reported to induce relaxation of conduit artery, whether the BDNF/TrkB (tropomyosin-related kinase) pathway is involved in the tone control of resistance arteries is not known. This study investigated TrkB receptors levels/localization and the vasomotor effect of the TrkB receptor agonist LM22A-4 in isolated third-order mesenteric arteries from rats. Immunostaining revealed the presence of both full-length and truncated TrkB receptors, especially at the endothelial level. By using wire myography, LM22A-4 induced vascular relaxation that was significantly decreased by cyclotraxin B as a non-competitive TrkB antagonist and fully prevented by endothelium removal. Inhibitors of NO, EDHF, PGI2 production and the PI3K/Akt pathways separately reduced LM22A-4 induced-relaxation. By contrast, inhibition of Raf/MEK, PLCγ and CaM/CaMKII pathways did not change the relaxant effect of LM22A-4. Interestingly, BDNF also induced an endothelium and TrkB-dependent relaxation. These results indicate that endothelial TrkB activation results in the relaxation of resistance vessels via PI3K/Akt-induced eNOS phosphorylation and production of EDHF and PGI2. These data are consistent with the contribution of the endothelial BDNF/TrkB pathway to the regulation of peripheral vascular tone. They also validate the use of LM22A-4 as a reliable pharmacological agent for studying the vascular effect of BDNF.

Keywords: BDNF; Mesenteric artery; TrkB receptor; Vasodilation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzamides / pharmacology*
  • Biological Factors / metabolism
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Epoprostenol / metabolism
  • In Vitro Techniques
  • Male
  • Mesenteric Arteries / drug effects*
  • Mesenteric Arteries / metabolism
  • Myography
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Phosphatidylinositol 3-Kinase / metabolism
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats, Wistar
  • Receptor, trkB / agonists*
  • Receptor, trkB / metabolism
  • Signal Transduction / drug effects
  • Vascular Resistance / drug effects*
  • Vasodilation / drug effects*
  • Vasodilator Agents / pharmacology*

Substances

  • Benzamides
  • Biological Factors
  • N,N',N'-tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
  • Vasodilator Agents
  • endothelium-dependent hyperpolarization factor
  • Nitric Oxide
  • Epoprostenol
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Phosphatidylinositol 3-Kinase
  • Ntrk2 protein, rat
  • Receptor, trkB
  • Proto-Oncogene Proteins c-akt